I had 3 biopsies from January 2020 to July 2022. The first two almost identical being Gleason 3+4 with <10% 4. However 6 months post HIFU it was Gleason 9 with 4+5 with 10% 5 and 70% 5 (see below).
I am curious as the cores are fragmented and so it’s hard to know what this means and if it makes any nomogram impossible or invalid. It seem ls the fragmented cores were NOT from the HIFU treated side which was the only positive cores on previous biopsies and the MRIs only show up possible malignancy on the HIFU side and not the side which has developed Gleason 9 high risk. (PSA always <10 and first 2 years <5)
See below : any comment in this report would be useful albeit hindsight as now on 18-24 months of HT following radiotherapy and negative PSMA/Pet. Any use in genomics ? Just try to plan my future management and recurrence risk time line
CLINICAL DETAILS
Elevated PSA. Post HIFU.
NATURE OF SPECIMEN
A. Right edge of treatment.
B. Left anterior.
C. Right base.
D. Left treated area.
GROSS DESCRIPTION
A. Seven fragmented cores of tissue largest measuring 14mm.
B. Seven cores of tissue largest measuring 10mm.
C. Four fragmented cores of tissue largest measuring 12mm.
D. Four cores of tissue largest measuring 11mm.
MICROSCOPIC EXAMINATION
A. Adenocarcinoma Gleason 4+5 overall (G4 70%, G3 20%, G5 10%), 4mm,
4mm, 4mm and 8mm, fragmented cores so percentage involvement not
assessable.
B. Seven prostatic cores with a group of small atypical acini suspicious for
malignancy.
C. Adenocarcinoma Gleason 3+4 overall (20% G4, no cribriform pattern), 2
foci measuring <1mm and 10mm (discontinuous), fragmented cores so
percentage involvement not assessable.
D. Four prostatic cores with high grade PIN and focal fibrosis.
DIAGNOSIS
Twenty two prostatic biopsies from 4 sites (post HIFU): Adenocarcinoma
Gleason 4+5 overall (Grade Group 5) at 2 sites (see text), maximum tumour
length 8mm. Neither perineurial nor lymphovascular invasion is seen.